Clinical Proteomics in Application to Predictive Diagnostics and Personalized Treatment of Diabetic Patients
Journal:
Current Proteomics
Volume:
5
Page:
35-44
Author(s):
Olga Golubnitschaja
Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
124-131
Author(s):
D. Daniel and N. S. Wilson
Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
132-140
Author(s):
Simone Fulda
Oncogenomics
Journal:
Current Drug Metabolism
Volume:
9
Page:
199-206
Author(s):
Virendra S. Gomase, Somnath Tagore, Karbhari V. Kale and Dayanand A. Bhiwgade
Cancer-Associated Carbonic Anhydrases and Their Inhibition
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
685-698
Author(s):
J. Pastorek, S. Pastorekova and M. Zatovicova
Synthesis and Cytotoxicity Studies of New Morpholino-Functionalised and N-Heteroaryl-Substituted Titanocene Anticancer Drugs
Journal:
Medicinal Chemistry
Volume:
4
Page:
91-99
Author(s):
M. Tacke, M. Hogan, J. Claffey and C. Pampillon
Molecule of the Month
Journal:
Current Topics in Medicinal Chemistry
Volume:
8
Page:
365-365
Author(s):
Robert R. Lavieri and Craig W. Lindsley
Antitumor Activity of Titanocene Y in Xenografted PC3 Tumors in Mice
Journal:
Letters in Drug Design & Discovery
Volume:
5
Page:
141-144
Author(s):
Catherine M. Dowling, James Claffey, Sandra Cuffe, Iduna Fichtner, Clara Pampillon, Nigel J. Sweeney, Katja Strohfeldt, R. William G. Watson and Matthias Tacke
Deregulation of the Akt Pathway in Human Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
27-36
Author(s):
Eriko Tokunaga, Eiji Oki, Akinori Egashira, Noriaki Sadanaga, Masaru Morita, Yoshihiro Kakeji and Yoshihiko Maehara
Cellular FLICE-Like Inhibitory Protein (C-FLIP): A Novel Target for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
37-46
Author(s):
Ahmad R. Safa, Travis W. Day and Ching-Huang Wu